Concepedia

Shangbin Liu

SL

Statistics

Publications

13

Citations

900

H-Index

10

Active since

2011

Affiliations

Shanghai Jiao Tong University(Current)

Chinese University of Hong Kong

University of California, San Francisco

Alnylam Pharmaceuticals (United States)

Klinikum Chemnitz

Shangbin Liu is an author at Shanghai Jiao Tong University specializing in medicine, stem cell therapies, and osteogenesis.

Top concepts

MedicineEducationStatisticsStem CellsEngineeringMeasurementOrthopedicsReliabilityOsteogenesisBiostatistics

Publications per year

2011–2023

13

Publications

13

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

Manisha Balwani, Eliane Sardh, Paolo Ventura et al. · New England Journal of Medicine · 2020 · 562 citations · Full text

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Laurent Gouya, Paolo Ventura, Manisha Balwani et al. · Hepatology · 2019 · 158 citations · Full text

Prediction Model for the Risk of HIV Infection among MSM in China: Validation and Stability

Yinqiao Dong, Shangbin Liu, Danni Xia et al. · International Journal of Environmental Research and Public Health · 2022 · 27 citations · Full text

Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study

Bruce Wang, Paolo Ventura, Kei‐ichiro Takase et al. · Orphanet Journal of Rare Diseases · 2022 · 27 citations · Full text

A novel method to improve the osteogenesis capacity of hUCMSCs with dual‐directional pre‐induction under screened co‐culture conditions

Qiong Rong, Shuyi Li, Yang Zhou et al. · Cell Proliferation · 2019 · 26 citations · Full text

Tissue Engineering, Engineering, Screened Co‐culture Conditions +25

1–5 of 13